IP Library › Granted Patent US 8,932,596
Granted Patent B2
US 8,932,596 · App. 13/413,565 · Granted Jan 13, 2015

Method of treating eosinophilic esophagitis

Inventors: Pierre-Henri Benhamou (Paris, FR); Lucie Mondoulet (Chatillon, FR)
Assignee: DBV Technologies
A61K39/35A61K35/20A61K36/00A61K36/47A61K36/899A61K35/57A61K35/646A61K9/7023A61K2039/54
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,932,596
App. No.
13/413,565
Granted
Jan 13, 2015
Kind
B2
Abstract

The present invention relates to the treatment of EE. More specifically, the invention relates to a new method of treating EE through the epicutaneous route. In particular, the method of the invention comprises applying to the skin of the subject a skin patch device, comprising a composition, under conditions allowing a contact between said composition and the skin. The present invention also relates to the skin patch device and to a use of the skin patch device in the manufacture of a composition for treating eosinophilic esophagitis in a subject.

Claims (8)

1. A method of treating a food-induced eosinophilic esophagitis in a subject, said eosinophilic esophagitis being characterized by an eosinophilic infiltration in the subject, the method comprising epicutaneously applying to the skin of the subject having eosinophilic infiltration a non-perforating skin patch device comprising a composition comprising, as the only active ingredient, a food allergen under conditions allowing contact between said composition and the skin, and in an amount sufficient to cause a decrease of eosinophilic infiltration in an esophagus or gut of the subject, said application resulting in a treatment of said eosinophilic esophagitis.

2. The method of claim 1 , wherein said subject suffers from allergy to one or more food allergens.

3. The method of claim 1 , wherein the food allergen is selected from the group consisting of milk, egg, wheat, soja, and peanuts.

4. The method of claim 1 , wherein more than one allergen is epicutaneously applied on the skin via one or more patch devices, separately, successively or simultaneously.

5. The method of claim 1 , wherein the composition is in dry form.

6. The method of claim 1 , wherein said method involves a repeated application of the skin patch device.

7. The method of claim 1 , wherein said composition further contains a pharmaceutically acceptable carrier.

8. A method of decreasing eosinophilic infiltration in an esophagus or gut of a subject having eosinophilic infiltration, said method comprising epicutaneously applying to the skin of the subject a non-perforating skin patch device comprising a composition comprising, as the only active ingredient, a food allergen under conditions allowing a contact between said composition and the skin, said application resulting in a decrease of eosinophilic infiltration in the esophagus or gut.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2012
From: BENHAMOU, PIERRE-HENRI; MONDOULET, LUCIE
To: DBV TECHNOLOGIES, INC.
Reel/Frame 028138/0142 →
Priority Claims (1)
EP 09305817 · Sep 7, 2009 · regional
Continuity (2)
Continuation PCTEP2010063019 · Sep 6, 2010
Related Publication 20120207815A1 · Aug 16, 2012